Literature DB >> 9563479

Quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in the rat.

J Tanuma1, H Shisa, H Hiai, S Higashi, Y Yamada, T Kamoto, Y Hirayama, H Matsuuchi, M Kitano.   

Abstract

The incidence of tongue carcinomas (TCs) induced by oral administration of 4-nitroquinoline 1-oxide in rats is strain dependent. The inbred Dark-Agouti (DA) strain showed a much higher susceptibility to large mass-forming infiltrative TCs than did the Wistar-Furth (WF) strain. Our previous study (M. Kitano et al, Jpn. J. Cancer Res., 87: 1097-1101, 1996) on crosses between these two strains postulated a dominant susceptibility gene in DA and a dominant resistance gene in WF rats. The present study mapped these loci by analyzing the backcrosses to each parent with simple sequence repeat polymorphisms. Five quantitative parameters were analyzed: (a) the number of TCs > 5 mm in diameter; (b) the total number of TCs per rat; (c) the diameter of the largest TCs (DTCmax values); (d) the number of non-TC cancers per rat; and (e) and the number of cancers of any site per rat. All of these parameters were closely correlated (P < 0.0001). DA rats had a semidominant gene (Stc1) favoring the development of 4-nitroquinoline 1-oxide-induced cancers on chromosome 19, closely linked to D19Mit9. Peak linkage was observed 4 cM distal from D19Mit9, with a logarithm of the odds (lod) score of 5.72 for the number of large TCs and 6.08 for the DTCmax. On the other hand, WF rats had a semidominant gene (Rtc1) mapped between D1Mit1 and D1Mit3, approximately 20 cM from D1Mit1, with a peak lod score of 3.30 for both the number of large TCs and the DTCmax. The main effect of Rtc1 seemed to be to reduce the size of the TCs. The action of these genes was dose dependent and cooperative. The final incidence of TC in DA, WF, F1, and backcross rats seemed to be explained by combinations of genotype at these two loci. Possible candidate genes for Stc1 and Rtc1 are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563479

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Basic consideration of research strategies for head and neck cancer.

Authors:  Jin Gao; Ben Panizza; Newell W Johnson; Scott Coman; Alan R Clough
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

2.  Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat.

Authors:  Xiaojiang Quan; Jean-François Laes; Daniel Stieber; Michèle Rivière; Jose Russo; Dirk Wedekind; Wouter Coppieters; Frédéric Farnir; Michel Georges; Josiane Szpirer; Claude Szpirer
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

Review 3.  Salivary Metabolomics for Oral Cancer Detection: A Narrative Review.

Authors:  Karthika Panneerselvam; Shigeo Ishikawa; Rajkumar Krishnan; Masahiro Sugimoto
Journal:  Metabolites       Date:  2022-05-12

4.  A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia.

Authors:  P P Dwivedi; S Mallya; A Dongari-Bagtzoglou
Journal:  Med Mycol       Date:  2008-06-10       Impact factor: 4.076

5.  Pthlh, a promising cancer modifier gene in rat tongue carcinogenesis.

Authors:  Hirohiko Suwa; Masato Hirano; Kouji Kawarada; Motohiko Nagayama; Michiko Ehara; Tomonari Muraki; Hayase Shisa; Aiko Sugiyama; Masahiro Sugimoto; Hiroshi Hiai; Motoo Kitano; Jun-Ichi Tanuma
Journal:  Oncol Rep       Date:  2013-11-20       Impact factor: 3.906

6.  Five quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue cancer in the rat.

Authors:  J I Tanuma; K Fujii; M Hirano; H Matsuuchi; H Shisa; H Hiai; M Kitano
Journal:  Jpn J Cancer Res       Date:  2001-06

7.  Novel cytological model for the identification of early oral cancer diagnostic markers: The carcinoma sequence model.

Authors:  Masami Kawaharada; Manabu Yamazaki; Satoshi Maruyama; Tatsuya AbÉ; Nyein Nyein Chan; Taiichi Kitano; Tadaharu Kobayashi; Takeyasu Maeda; Jun-Ichi Tanuma
Journal:  Oncol Lett       Date:  2022-01-11       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.